Core Viewpoint - Pagaya Technologies Ltd. (PGY) has seen a 6.4% increase in share price over the past four weeks, closing at $24.88, with analysts suggesting a potential upside of 64% based on a mean price target of $40.8 [1] Price Targets - The average price target consists of 10 estimates ranging from a low of $27.00 to a high of $54.00, with a standard deviation of $7.55, indicating variability among analysts [2] - The lowest estimate suggests an 8.5% increase from the current price, while the highest indicates a potential upside of 117% [2] Analyst Consensus and Earnings Estimates - Analysts are increasingly optimistic about PGY's earnings prospects, as evidenced by a strong agreement in revising EPS estimates higher, which correlates with potential stock price increases [4][11] - Over the last 30 days, the Zacks Consensus Estimate for the current year has risen by 28.1%, with one estimate moving higher and no negative revisions [12] Zacks Rank - PGY holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating a strong potential for upside [13] Caution on Price Targets - While price targets are a common metric for investors, relying solely on them may not be prudent due to historical inaccuracies in predicting stock price movements [3][7][10]

Core Viewpoint - Sprinklr (CXM) shows potential for upside with a mean price target of $10.5, indicating a 32.9% increase from its current price of $7.9, following a 5.1% gain over the past four weeks [1]. Price Targets and Analyst Estimates - The mean estimate consists of eight short-term price targets with a standard deviation of $3.12, suggesting variability in analyst predictions. The lowest estimate is $8.00 (1.3% increase), while the highest is $17.00 (115.2% increase) [2]. - A low standard deviation indicates a high degree of agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9]. Earnings Estimates and Analyst Sentiment - Analysts have shown increasing optimism about CXM's earnings prospects, with a strong consensus on revising EPS estimates higher, which correlates with potential stock price increases [11]. - The Zacks Consensus Estimate for the current year has risen by 6.8% over the past month, with two estimates increasing and no negative revisions [12]. - CXM holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for near-term upside [13]. Caution on Price Targets - Solely relying on consensus price targets for investment decisions may not be wise, as analysts' ability to set unbiased targets has been questioned [3]. - Price targets can often mislead investors, and while they should not be ignored, they should be approached with skepticism [10].

Shares of Theravance Biopharma (TBPH) have gained 25.8% over the past four weeks to close the last trading session at $18.7, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $24.43 indicates a potential upside of 30.6%.The mean estimate comprises seven short-term price targets with a standard deviation of $8.85. While the lowest estimate of $13.00 indicates a 30.5% decline from t ...

Shares of SSR Mining (SSRM) have gained 10.1% over the past four weeks to close the last trading session at $21.44, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $27.23 indicates a potential upside of 27%.The mean estimate comprises 10 short-term price targets with a standard deviation of $4.63. While the lowest estimate of $18.70 indicates a 12.8% decline from the current pri ...

Core Viewpoint - Biohaven Ltd. (BHVN) shows significant potential for upside, with a mean price target of $20.75 indicating a 127.5% increase from its current price of $9.12, reflecting strong analyst optimism about the company's earnings prospects [1][11]. Price Targets and Analyst Consensus - The average price target for BHVN is based on 16 estimates, ranging from a low of $9.00 to a high of $50.00, with a standard deviation of $12.14, indicating variability in analyst predictions [2]. - The lowest estimate suggests a minor decline of 1.3%, while the highest estimate indicates a potential upside of 448.3% [2]. - A low standard deviation signifies a strong agreement among analysts regarding the stock's price direction, which can serve as a starting point for further research [9]. Earnings Estimates and Analyst Revisions - Analysts have shown increasing optimism about BHVN's earnings, with eight estimates revised higher in the last 30 days and no negative revisions, leading to a 5.9% increase in the Zacks Consensus Estimate [12][11]. - The company holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, suggesting a strong potential for upside [13]. Caution on Price Targets - While price targets are a common tool for investors, they can often mislead, as empirical research indicates that they rarely predict actual stock price movements accurately [7][10]. - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8].

Core Viewpoint - Grindr Inc. (GRND) shares have increased by 2.4% over the past four weeks, closing at $13.51, with a mean price target of $21.75 indicating a potential upside of 61% [1] Price Targets - The average price target consists of four estimates ranging from a low of $20.00 to a high of $26.00, with a standard deviation of $2.87, suggesting a potential increase of 48% to 92.5% from the current price [2] - A low standard deviation indicates a strong agreement among analysts regarding the price targets, which can be a useful indicator for further research [9] Analyst Sentiment - Analysts have shown increasing optimism about GRND's earnings prospects, as evidenced by a positive trend in earnings estimate revisions, which correlates with potential stock price movements [11] - The Zacks Consensus Estimate for the current year has risen by 12.8% over the past month, with no negative revisions [12] Zacks Rank - GRND holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating a strong potential upside [13] Conclusion on Price Targets - While the consensus price target may not be a reliable indicator of the extent of potential gains, it does provide a directional guide for price movement [14]

Core Viewpoint - Q2 Holdings (QTWO) shares have increased by 17.3% in the past four weeks, closing at $71.01, with a potential upside of 26.3% based on Wall Street analysts' mean price target of $89.71 [1] Price Targets and Analyst Estimates - The mean estimate consists of 14 short-term price targets with a standard deviation of $10.67, indicating variability among analysts; the lowest estimate is $74.00 (4.2% increase), while the highest is $110.00 (54.9% increase) [2] - A low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement direction [9] Earnings Estimates and Analyst Consensus - Analysts are optimistic about QTWO's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which have increased by 17.4% over the past month with five upward revisions and no negative ones [11][12] - QTWO holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13] Caution on Price Targets - While price targets are commonly referenced by investors, they can often mislead; empirical research shows that they rarely indicate actual stock price movements [7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]

Core Viewpoint - Rithm (RITM) shares have increased by 3.1% in the past four weeks, closing at $11.33, with a potential upside of 25.4% based on Wall Street analysts' mean price target of $14.21 [1] Price Targets - The average price target consists of seven estimates ranging from a low of $12.50 to a high of $16.00, with a standard deviation of $1.19, indicating a potential increase of 10.3% to 41.2% from the current price [2] - A low standard deviation suggests a high degree of agreement among analysts regarding the stock's price movement [9] Analyst Sentiment - Analysts are optimistic about RITM's earnings prospects, as indicated by a positive trend in earnings estimate revisions, which historically correlates with stock price movements [4][11] - The Zacks Consensus Estimate for the current year has risen by 0.2% over the past month, with one estimate increasing and no negative revisions [12] Zacks Rank - RITM holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, suggesting a strong potential upside [13] Caution on Price Targets - While price targets are a common metric, they should be approached with skepticism as they can mislead investors; analysts may set overly optimistic targets due to business incentives [3][8][10]

Oddity Tech (ODD) closed the last trading session at $43.14, gaining 0.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $68 indicates a 57.6% upside potential.The mean estimate comprises 11 short-term price targets with a standard deviation of $11.73. While the lowest estimate of $46.00 indicates a 6.6% increase from the current price level, the most optimistic analyst expects th ...

Shares of Alarm.com Holdings (ALRM) have gained 6.3% over the past four weeks to close the last trading session at $51.55, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $66.71 indicates a potential upside of 29.4%.The average comprises seven short-term price targets ranging from a low of $55.00 to a high of $85.00, with a standard deviation of $12.19. While the lowest estimate ...